Rohan Palekar, SVP & Chief Commercial Officer at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 25,000 shares at $12.50 ($288K) on 2014-09-15, disclosed to the SEC on 2014-09-17.
Scheduled sale ($288k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 10,000 | $100K | 34.8% |
| 2 | $12.50 | 15,000 | $188K | 65.2% |
| Total | $11.50 avg | 25,000 | $288K | 100% |
| Filing → |
| ETNB | SELL | 2024-04-03 | $1.2M | — | Filing → |
| ETNB | SELL | 2024-02-28 | $48K | — | Filing → |
| ETNB | SELL | 2024-01-03 | $560K | — | Filing → |